BACKGROUND: Diabetes mellitus in early pregnancy increases the risk of birth defects in infants. Maternal hyperglycemia stimulates the expression of nitric oxide synthase 2, which can be regulated by transcription factors of the nuclear factor-kB family. Increases in reactive nitrogen species generate intracellular stress conditions, including nitrosative, oxidative, and endoplasmic reticulum stresses, and trigger programmed cell death (or apoptosis) in the neural folds, resulting in neural tube defects in the embryo. Inhibiting nitric oxide synthase 2 can reduce neural tube defects; however, the underlying mechanisms require further delineation. Targeting nitric oxide synthase 2 and associated nitrosative stress using naturally occurring phytochemicals is a potential approach to preventing birth defects in diabetic pregnancies. OBJECTIVE: This study aims to investigate the effect of quercetin-3-glucoside, a naturally occurring polyphenol flavonoid, in reducing maternal diabetes-induced neural tube defects in an animal model, and to delineate the molecular mechanisms underlying quercetin-3-glucoside action in regulating nitric oxide synthase 2 expression. STUDY DESIGN: Female mice (C57BL/6) were induced to develop diabetes using streptozotocin before pregnancy. Diabetic pregnant mice were administered quercetin-3-glucoside (100 mg/kg) daily via gavage feeding, introduction of drug to the stomach directly via a feeding needle, during neurulation from embryonic day 6.5e9.5. After treatment at embryonic day 10.5, embryos were collected and examined for the presence of neural tube defects and apoptosis in the neural tube. Expression of nitric oxide synthase 2 and superoxide dismutase 1 (an antioxidative enzyme) was quantified using Western blot assay. Nitrosative, oxidative, and endoplasmic reticulum stress conditions were assessed using specific biomarkers. Expression and posttranslational modification of factors in the nuclear factor-kB system were investigated.
Introduction
Diabetes mellitus (DM) in early pregnancy can cause birth defects in infants, a complication known as diabetic embryopathy. 1, 2 Defects in the central nervous system, including anencephaly, exencephaly, and spina bifida, are the result of a failure in neural tube formation during early embryogenesis, collectively referred to as "neural tube defects" (NTDs). 3 The development of NTDs is associated with increased programmed cell death (apoptosis) in the neural folds during neurulation. 1 Although the mechanisms underlying apoptosis induction are not fully understood, an inflammation-like condition with elevated nitric oxide (NO) levels has been observed in the embryos of diabetic animals. 4e6 High levels of reactive nitrogen species (RNS), derived from NO, augment protein S-nitrosylation and nitration, manifesting as nitrosative stress. 7, 8 The perturbation of protein activity affects the function of the mitochondria, leading to generation of reactive oxygen species, and the endoplasmic reticulum (ER), resulting in disruption of protein folding, to further exacerbating oxidative and ER stresses. 9e11 Reactive oxygen species can be scavenged by antioxidative enzymes, including superoxide dismutases (Sod) and catalase. 12 However, these enzymes in the embryo are suppressed by maternal hyperglycemia. 13 NO is generated by NO synthases (NOS), including NOS1 (neuronal), Original Research ajog.org NOS2 (inducible), and NOS3 (endothelial). The elevation of NO levels in the embryos of diabetic animals may be ascribed to the dramatic up-regulation of Nos2; 5 because other Nos isoforms are down-regulated. 14, 15 The pivotal role of Nos2 in diabetic embryopathy has been demonstrated in mouse models where deletion of the Nos2 gene or inhibition of Nos2 leads to significant decreases in the rates of embryonic and fetal abnormalities under maternal hyperglycemic conditions. 5, 16 The expression of the NOS2 gene is regulated by nuclear proteins, including nuclear factor (NF)-kB transcription factors. 17, 18 NF-kB proteins, including p50 and p65, form dimers and are retained in the cytoplasm by inhibitor of kB (IkB). 19 
Phosphorylation of IkB by
IkB kinase (IKK) triggers IkB degradation and releases p50/p65 complex. 20 The NF-kB dimer translocates into the nucleus to regulate target gene transcription. 19 Targeting NOS2 may be an effective approach to reduction of embryonic malformations. 5, 16 NOS2 inhibiting agents that have low toxicity and are potentially applicable in human beings have been explored to prevent diabetesinduced birth defects. 21 Among them, quercetin (QC), a naturally occurring flavonoid in fruits, has been shown to reduce Nos2 expression in the embryos of diabetic mice. 21 However, QC has low water solubility and low rate of absorption in the gastrointestinal tract. 22, 23 In comparison, its derivative, QC-3-glucoside (Q3G) (isoquercetin), has higher water solubility and higher absorption rates, due to the presence of the glucoside group. 22, 24, 25 Q3G also possesses antioxidative and antiinflammatory properties. 26, 27 These characteristics make Q3G a promising candidate intervention to reduce birth defects in diabetic pregnancies.
AJOG at a Glance
Why was this study conducted? Diabetes mellitus in early pregnancy increases the risk of birth defects in infants. The underlying mechanisms and interventions for prevention remain to be explored.
Key findings
Oral treatment with naturally occurring quercetin-3-glucoside (Q3G) reduces neural tube defects in embryos of diabetic mice. Q3G suppresses the activation of nuclear factor-kB transcription factors, leading to decreases in nitric oxide synthase 2 expression and alleviation of nitrosative stress.
What does this add to what is known?
Dietary supplementation of Q3G may be a promising approach to preventing birth defects induced by diabetes in pregnancy. insulin-producing b cells in the pancreas. DM was defined as blood glucose levels reaching !14 mmol/L (250 mg/dL). Female mice injected with citrate buffer were used as nondiabetic (ND) controls. Euglycemia (w8 mmol/ L) was restored in the diabetic mice by subcutaneous implantation of insulin pellets (Linshin Canada, Scarborough, Ontario, Canada). Female mice were paired with normal male mice of the same strain in the afternoon. The presence of the vaginal plug the next morning was designated as embryonic day (E) 0.5. At E5.5, insulin implants were removed to make the female mice hyperglycemic before the beginning of neurulation (E8.5). 28 Pregnant mice were fed Q3G (CAS no. 21637-25-2; Cayman Chemical, Ann Arbor, MI) suspended in water at 100 mg/kg body weight, or water (vehicle [VEH] 0.1 mL) via gavage feeding, injection of the solution into the stomach via a feeding needle, once a day from E6.5e9.5. Maternal blood glucose levels were monitored every day. Three groups were included in this study: ND, DMþVEH, and DMþQ3G. At E10.5 (late stage of neurulation 29 ), embryos were collected for examination of NTDs.
Terminal deoxynucleotidyl transferase-mediated 2 0 -deoxyuridine 5 0 -triphosphate nick end labeling assay
Terminal deoxynucleotidyl transferasemediated 2 0 -deoxyuridine 5 0 -triphosphate nick end labeling (TUNEL) assay was used to detect DNA fragmentation in apoptotic cells.
30 E10.5 embryos were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) (pH 7.4) at 4 C for 24 hours and embedded in paraffin wax through dehydration with ethanol and xylene. Tissue sections in 5-mm thickness were cut using a microtome. Tissue sections were dewaxed in xylene and rehydrated through a reverse ethanol concentration series to water.
After equilibration with PBS, the tissue sections were treated with proteinase K (20 mg/mL) for 15 minutes at room temperature, incubated with TUNEL labeling mix containing 2 0 -deoxyuridine 5 0 -triphosphate-fluorescein (Roche, Indianapolis, IN) for 2 hours at 37 C, and counterstained with 4 0 ,6-diamidino-2-phenylindole. The sections were observed under a fluorescent microscope (Zeiss, Thornwood, NY). Microscopic images were captured using a charge-coupled device camera connected to an image analysis station and arranged using image analyzing software program. Tan et al. Quercetin-3-glucoside prevents neural tube defects in embryos of diabetic mice. Am J Obstet Gynecol 2018.
FIGURE 2
Effect of quercetin-3-glucoside (Q3G) on apoptosis in dorsal regions of neural tube 
Western blot assay
The neural tissues in the brain regions of the E10.5 embryos were isolated and individually collected using fine scissors under a stereo-microscope in cold PBS. The tissues were homogenized in a lysis buffer [25 mmol/L Tris-HCl (pH 7.6), 150 mmol/L NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate] containing protease and phosphatase inhibitor cocktails (Thermo Scientific, Rockford, IL). The tissue homogenates were centrifuged at 14,000 rpm for 15 minutes at 4 C to obtain supernatants.
Protein samples were resolved in 10% polyacrylamide gel using electrophoresis in presence of sodium dodecyl sulfate and blotted onto polyvinylidene fluoride membranes (Millipore, Billerica, MA). After blocking with 10% nonfat milk or bovine serum albumin, the membranes were incubated with primary antibodies for 16 hours at 4 C. The primary antibodies were against Nos2, Sod1, immunoglobulin-binding protein, phosphorylated (p) eukaryotic initiation factor Original Research OBSTETRICS ajog.org 2a, p-inositol-requiring enzyme (Ire) 1a, p65, Ikka, IkBa, and p-IkBa (Cell Signaling Technology, Beverly, MA). After incubation with horseshoe radish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) for 1 hour at room temperature, signals were detected using SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific), captured using a charge-coupled device camera, and analyzed using the program in UVP Bioimage system (UVP, Upland, CA).
The same membranes were stripped using Restore Western blot stripping buffer (Thermo Scientific) and probed again with an antibody against b-actin 
Statistical analyses
NTD rate was calculated as a percentage of the embryos with NTDs out of the total number of embryos. Log binomial models for clustered data were applied to compare the NTD rates between groups. Data of protein levels relative to those of b-actin on Western blots, presented as mean AE SD, were analyzed using the exact Wilcoxon rank sum test. P < .05 was considered statistically significant.
Results

Effect of Q3G on embryonic malformations in diabetic pregnancies
Diabetic pregnant mice were treated with Q3G from E6.5e9.5. The NTD rate at E10.5 in the DMþQ3G group was significantly lower than that in the DMþVEH group (fed with water alone), and similar to that in the ND group (P < .001) (Figure 1 and Table) .
Decreases in cell apoptosis in the neural tube by Q3G treatment NTD formation is associated with increased apoptosis in the neuroepithelium. 28 The phenomenon was seen in the DMþVEH group, manifested as high levels of TUNEL-positive signals (apoptosis) in the dorsal region of the neural tube in the sites of NTDs (Figure 2, B) . In the DMþQ3G group, the apoptotic signals were lower than those in the DMþVEH group in the similar regions of the neural tube, but similar as in the ND group (Figure 2, C) .
Restoration of Nos2 and Sod1 expression by Q3G treatment
Maternal hyperglycemia has been shown to increase the expression of Nos2 and suppress the expression and activity of Sod1 in the embryo. 4e6,21,31 To address the question of whether Q3G affects these enzymes, the levels of these proteins in the malformed embryos from the DMþVEH group, and normal embryos from the ND group and DMþQ3G group were assessed and compared. Nos2 expression was significantly increased in the DMþVEH group, compared with that in the ND group (Figure 3, A) . Q3G treatment significantly reduced the levels of Nos2 expression to the levels in the ND group, compared with those in the DMþVEH group (P < .05) (Figure 3, A) .
Maternal hyperglycemia (DMþVEH group) decreased the levels of Sod1 in the embryos, compared with the ND group (Figure 3, B) . Q3G treatment significantly increased Sod1 expression to the similar levels in the ND group, ajog.org OBSTETRICS Original Research compared with those in the DMþVEH group (P < .05) (Figure 3, B) .
Alleviation of intracellular stress conditions by Q3G treatment
In association with the changes in Nos2 and Sod1 expression after Q3G treatment, the levels of 3-nitrotyrosine, a marker for nitrosative and oxidative stresses, were also decreased in the DMþQ3G group, compared with those in the DMþVEH group (P < .05), to similar levels in the ND group (Figure 3, C) .
Nitrosative and oxidative stress can perturb the activity of the ER, leading to ER stress. 16, 21 Significant increases in the ER stress markers immunoglobulinbinding protein, p-eukaryotic initiation factor 2a, and p-inositol-requiring enzyme 1a were observed in the embryos of the DMþVEH group, compared with the ND group (Figure 4) . Q3G treatment alleviated ER stress, indicated by significant decreases in these same markers in the DMþQ3G group, compared with the DMþVEH group (P < .05) (Figure 4 ).
Modulation of NF-kB signaling by Q3G treatment
The expression of the NOS2 gene is regulated by the transcription factors in the NF-kB signaling system, specifically p65. 17, 18 In the embryos of diabetic mice (DMþVEH group), the expression p65 was significantly increased, compared with the ND group ( Figure 5, A) . Treatment with Q3G (DMþQ3G group) significantly decreased the expression of p65 to the levels in the ND group (P < .05) (Figure 5, A) .
Activation of NF-kB transcription factors requires IKK to phosphorylate IkB for degradation. 19 The expression of Ikka was significantly increased in the embryos of the DMþVEH group, compared with that in the ND group (P < .05) (Figure 5, B) . Q3G treatment (DMþQ3G group) significantly decreased the levels of Ikka, compared with the DMþVEH group (P < .05) ( Figure 5, B) . In association with the upregulation of Ikka, the levels of p-IkBa were increased and those of total IkBa were significantly decreased in the embryos of the DMþVEH group (P < .05), compared with those in the ND group ( Figure 5, C) . Treatment with Q3G (DMþQ3G group) significantly reduced the levels of p-IkBa and increased the levels of total IkBa, compared with the DMþVEH group (P < .05), to those similar to the ND group ( Figure 5, C) .
Comment
Principal findings of the study
Maternal hyperglycemia-induced cell apoptosis and NTDs in the embryo are associated with nitrosative stress, which is mediated by high levels of NO and RNS produced by NOS2. 16, 21 Blocking NOS2 activity with inhibitors can alleviate nitrosative stress and reduce embryonic malformations in diabetic embryopathy. 5, 16 Here, we showed that the naturally occurring phytochemical Q3C inhibited Nos2 expression, ameliorated nitrosative stress, and reduced NTDs in diabetic embryopathy. In addition, Q3G up-regulated Sod1, thereby enhancing the antioxidative capacity of the cells. These effects resulted in the alleviation of oxidative stress and ER stress and decreased apoptosis in the developing neural tube.
Regulation of Nos2 expression by Q3G in diabetic embryopathy
The expression of NOS2 is regulated by transcription factors in the NF-kB family, notably the p50/p65 dimer complex. 17, 18 In the neural tube of the embryos of diabetic mice, p65 expression is up-regulated, suggesting that the NF-kB signaling responds to hyperglycemia. The p50/p65 dimer is detained in the cytoplasm by IkB. IKK phosphorylates IkB for degradation, and thus, releases the p50/p65 complex to allow them to translocate into the nucleus to regulate gene expression ( Figure 6 ). 19 Maternal hyperglycemia may stimulate the inflammation-like response in the Potential actions of quercetin-3-glucoside (Q3G) in suppression of nitric oxide synthase (NOS) 2 expression
Maternal hyperglycemia increases expression of p65, which forms complex with p50, to activate NOS2 transcription. Hyperglycemia also up-regulates IkB kinase (IKK), which phosphorylates IkB for degradation. p50/p65 Complex is released and translocates into nucleus to regulate gene transcription. Q3G suppresses expression of p65 and IKK, and thus, decreases expression of NOS2, and consequent nitrosative stress. Original Research OBSTETRICS ajog.org embryo by increasing IKK expression. The up-regulation of IKKa leads to removal of IkBa, indicated by the increases in IkBa phosphorylation and decreases in total IkBa levels. The increases in p65 expression and nuclear translocation potentially up-regulate NOS2 transcription, and ultimately elevate RNS levels and nitrosative stress ( Figure 6 ).
Treatment with Q3G ameliorated the effects of hyperglycemia on the factors in the NF-kB system and restore their levels to those in the ND ("normal") conditions ( Figure 6 ). The effects of Q3G treatment may result in down-regulation of Nos2 expression and alleviation of intracellular stresses. Future investigations are aimed at delineating the action of Q3G in the modulation of the NF-kB system.
Q3G as a candidate agent for preventing embryonic malformations in diabetic pregnancy
Q3G is a glucoside derivative of QC, which has been shown to reduce NTDs in diabetic embryopathy. 21 Compared with QC and other derivatives, Q3G has higher water solubility, higher absorption rate in the gastrointestinal tract, and higher bioavailability in organ systems. 22, 24, 25 Unlike other QC derivatives, Q3G can also be transported via glucose carriers, increasing its bioavailability in cells.
32 Q3G has been shown to possess antioxidative and antiinflammatory properties, 26 protect neurons from ischemia-reperfusion injury, and ameliorate neurodegenerative diseases. 27, 33 The present study demonstrated that Q3G reduced NTDs in the embryos of diabetic mice. The beneficial effects of Q3G may extend beyond only preventing malformations in the central nervous system. Animal studies have shown that hyperglycemia induces similar molecular dysregulation in the cardiovascular system, especially in terms of Nos expression and nitrosative stress. 5, 13, 16 Thus, it is conceivable that a Q3G supplement may have broad action against diabetic embryopathy.
One of the criteria for selecting a therapeutic agent for use in pregnancy is its safety for the embryo and fetus. Studies in human beings and animals have shown that flavonoids, including Q3G, have no adverse effects when used in low dosages (chronic use) or high dosages (acute treatment). 34, 35 Although flavonoids are present in foods, 36, 37 therapeutic effects of certain forms of flavonoid require increasing the amount of intake through dietary supplementation. In the present study, the dose of Q3G is comparable to the high levels of human intake of flavonoids.
36, 37 The data from the animal study provide a scientific basis for clinical trials to further optimize the dosage for human pregnancies.
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